Chart

Intellia Therapeutics, Inc.

NTLA

Jan 1 1970 00:00:00

12.20

▲0.1500▲1.24%

Open11.95

High12.43

Low11.95

Close12.05

Volume103.81k

EPS

-5.49

P/E

-2.22

Market Cap

1.24B

Outstanding Shares

101.58M

Soon

Sentiment

Soon

Options

Recent Filings

ID: 0001193125-24-244201

ID: 0000950170-24-112980

ID: 0000950170-24-093907

ID: 0000950170-24-093339

ID: 0000950170-24-086061

ID: 0000950170-24-086046

ID: 0001193125-24-181015

ID: 0000950170-24-081259

ID: 0000950170-24-081258

ID: 0001193125-24-168545

You might find these companies interesting

Achieve Life Sciences, Inc.

In Vitro & In Vivo Diagnostic Substances (2835)

Mymd Pharmaceuticals, Inc.

In Vitro & In Vivo Diagnostic Substances (2835)

Virax Biolabs Group Ltd

In Vitro & In Vivo Diagnostic Substances (2835)

Quidelortho Corp

In Vitro & In Vivo Diagnostic Substances (2835)

In Vitro & In Vivo Diagnostic Substances (2835)

Oruka Therapeutics, Inc.

In Vitro & In Vivo Diagnostic Substances (2835)

Idexx Laboratories Inc /De

In Vitro & In Vivo Diagnostic Substances (2835)

In Vitro & In Vivo Diagnostic Substances (2835)

Myriad Genetics Inc

In Vitro & In Vivo Diagnostic Substances (2835)

Aspira Women's Health Inc.

In Vitro & In Vivo Diagnostic Substances (2835)

Navidea Biopharmaceuticals, Inc.

In Vitro & In Vivo Diagnostic Substances (2835)

Alpha Teknova, Inc.

In Vitro & In Vivo Diagnostic Substances (2835)

Genetic Technologies Ltd

Biological Products, (No Diagnostic Substances) (2836)

Pharmaceutical Preparations (2834)